Detailed View
ABT - Abbott Laboratories
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
189,892,263,936
Adj EBIT (TTM)
8,064,000,000
Enterprise Value
217,549,263,936
Last Price
109.74
Earnings Yield
3.71%
Return on Capital
20.71%
Capital
38,946,000,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 12,593,000,000 | 1,693,000,000 |
| 2026-03-31 | 10-Q | 2026 | 11,164,000,000 | 1,345,000,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 11,459,000,000 | 2,251,000,000 |
| 2025-09-30 | 10-Q | 2025 | 11,369,000,000 | 2,057,000,000 |
| 2025-06-30 | 10-Q | 2025 | 11,142,000,000 | 2,052,000,000 |
| 2025-03-31 | 10-Q | 2025 | 10,358,000,000 | 1,693,000,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 10,974,000,000 | 1,911,000,000 |
| 2024-09-30 | 10-Q | 2024 | 10,635,000,000 | 1,859,000,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.